May 12, 2023 - Glioblastoma Clinical Trial Results and more news…

Published: 12 May 2023

May 12, 2023

Carthera’s SonoCloud-9 Device Facilitates Delivery of Chemotherapy to Glioblastomas

Results from a US clinical trial using the SonoCloud-9^® device for the treatment of recurrent glioblastomas were published in The Lancet Oncology.
Investigators implanted the device in 17 participants then used it to repeatedly open the blood-brain barrier and deliver chemotherapy.
The method was safe, well tolerated, and delivered up to a six-fold increase in chemotherapy concentration.

Affordability and Access: The Barriers to Noninvasive Therapies for Women

Woman talks to their doctor in an office

In this blog, the Foundation’s Chief Scientific Officer discusses factors affecting women’s healthcare, using uterine fibroids as a model.
Focused ultrasound has been approved to treat fibroids for 20 years, so why aren’t more patients able to receive this noninvasive treatment?

Focused Ultrasound Featured on Popular Podcast

The Truth About Your Future wit Ric Edelman podcast

Foundation Chairman Neal Kassell, MD, discussed focused ultrasound on Ric Edelman’s podcast, “The Truth About Your Future.”
Dr. Kassell provided an overview of the technology and its potential to treat the brain, cancer, and even veterinary conditions.
The episode is called "Cool Examples of How Exponential Technologies Will Improve Our Lives."

Watch Now

AdvaMed Workshop on How to Apply for NIH Funding

NIH provides more than $1.2 billion in funding annually through its Small Business Innovation Research and Technology Transfer programs.
The virtual workshop will help small businesses developing game-changing technologies craft competitive proposals.
The event is June 20 and 22, and registration is free for AdvaMed members.

Learn More and Register

Meet Jeffrey: Patient with OCD Finds Relief with Focused Ultrasound

May is Mental Health Awareness Month, and it is estimated that 2.5 million adults in the US suffer from obsessive-compulsive disorder (OCD).
Jeffrey was the first person to undergo focused ultrasound for his OCD in a clinical trial in Toronto.
This profile from 2019 reveals how the treatment changed his daily life.

Forwarded this email by a friend? Sign up to receive these emails here.

Related Topics

WEBINAR “FUS and BBBO for Drug Delivery” by Elisa Konofagou, PhD, from Columbia University | May 18 at 11:00 am Eastern | Hosted by the International Society for Therapeutic Ultrasound

Glioblastoma Patient Shares His Clinical Trial Experience | CBS News Philadelphia

Abstracts are Due June 9 for the Society of NeuroOncology’s Annual Meeting

See All Recent News

Events

May 16-20, 2023 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, Los Angeles, CA

May 18-19, 2023 3rd International Tremor Congress 2023, New York, NY

June 2-6, 2023 American Society of Clinical Oncology (ASCO) Annual Meeting 2023, Chicago, IL

See All Upcoming Events

Do you have news for our newsletter? Tell us about it!

“All women should be able to choose a safe, effective, and noninvasive treatment option for their fibroids that ends pain and suffering, allows a quick return to work and normal life, and safeguards their ability to have children.”

‒ Jessica Foley, PhD